HK1123544A1 - Process for making trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3- dimethylpiperazine - Google Patents
Process for making trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3- dimethylpiperazineInfo
- Publication number
- HK1123544A1 HK1123544A1 HK08109478.4A HK08109478A HK1123544A1 HK 1123544 A1 HK1123544 A1 HK 1123544A1 HK 08109478 A HK08109478 A HK 08109478A HK 1123544 A1 HK1123544 A1 HK 1123544A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- phenylindan
- dimethylpiperazine
- chloro
- making trans
- trans
- Prior art date
Links
- 239000012971 dimethylpiperazine Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
- C07C25/18—Polycyclic aromatic halogenated hydrocarbons
- C07C25/22—Polycyclic aromatic halogenated hydrocarbons with condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
- C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200500237 | 2005-02-16 | ||
PCT/DK2006/000086 WO2006086984A1 (en) | 2005-02-16 | 2006-02-14 | Process for making trans-1-((1r, 3s)-6-chloro-3-phenylindan-1-yl)-3, 3-dimethylpiperazine |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1123544A1 true HK1123544A1 (en) | 2009-06-19 |
Family
ID=38323790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08109478.4A HK1123544A1 (en) | 2005-02-16 | 2008-08-26 | Process for making trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3- dimethylpiperazine |
Country Status (20)
Country | Link |
---|---|
US (2) | US8569499B2 (ru) |
EP (1) | EP1853574A1 (ru) |
JP (1) | JP5148289B2 (ru) |
KR (1) | KR101364365B1 (ru) |
CN (1) | CN101137632B (ru) |
AR (1) | AR054735A1 (ru) |
AU (1) | AU2006215955B2 (ru) |
BR (1) | BRPI0607438A2 (ru) |
CA (1) | CA2597615C (ru) |
EA (1) | EA018059B1 (ru) |
HK (1) | HK1123544A1 (ru) |
IL (1) | IL184553A (ru) |
MX (1) | MX2007009814A (ru) |
MY (1) | MY148242A (ru) |
NO (1) | NO20074642L (ru) |
NZ (1) | NZ556517A (ru) |
TW (1) | TWI453198B (ru) |
UA (1) | UA106191C2 (ru) |
WO (1) | WO2006086984A1 (ru) |
ZA (1) | ZA200705984B (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004265021B2 (en) | 2003-08-18 | 2010-05-27 | H. Lundbeck A/S | Succinate and malonate salt of trans-4-(IR,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament |
TWI453198B (zh) * | 2005-02-16 | 2014-09-21 | Lundbeck & Co As H | 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s)-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法 |
TWI376373B (en) | 2005-02-16 | 2012-11-11 | Lundbeck & Co As H | Crystalline base of a pharmaceutical compound |
TW200819426A (en) | 2006-08-31 | 2008-05-01 | Lundbeck & Co As H | Novel indane compounds |
TW201102370A (en) * | 2009-07-07 | 2011-01-16 | Lundbeck & Co As H | Manufacture of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl piperazine |
EP2639216B1 (en) * | 2010-11-09 | 2018-07-11 | Kaneka Corporation | Halogenated indenones and method for producing optically active indanones or optically active indanols by using same |
CN103429577A (zh) * | 2011-01-07 | 2013-12-04 | H.隆德贝克有限公司 | 4-((1r,3s)-6-氯-3-苯基-茚满-1-基)-1,2,2-三甲基哌嗪和1-((1r,3s)-6-氯-3-苯基-茚满-1-基)-3,3-二甲基哌嗪的拆分方法 |
LT2720989T (lt) * | 2011-06-20 | 2016-11-25 | H. Lundbeck A/S | Deuterinti 1-piperazin-3-fenilindanai, skirti šizofrenijos gydymui |
JP5838628B2 (ja) * | 2011-07-25 | 2016-01-06 | 東ソー株式会社 | N−アルキルピペラジン類の製造方法 |
AR094054A1 (es) | 2012-12-19 | 2015-07-08 | H Lundbeck As | 6-cloro-3-(fenil-d₅)-inden-1-ona y uso de la misma |
JP6786761B2 (ja) * | 2015-05-26 | 2020-11-18 | ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. | Sfcによるキラル異性体の分離 |
US20210395208A1 (en) | 2018-10-29 | 2021-12-23 | H. Lundeck A/S | Amorphous compounds of formula (i) and amorphous compounds of formula (i) salts |
WO2020114853A1 (en) | 2018-12-03 | 2020-06-11 | H. Lundbeck A/S | Prodrugs of 4-((1r,3s)-6-chloro-3-phenyl-2,3-dihydro-1h-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1/r,3s)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1h-inden-1-yl)-2,2-dimethy-1-(methyl-d3)piperazine |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4031216A (en) * | 1974-08-12 | 1977-06-21 | Knoll A.G. Chemische Fabriken | 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines |
IE50867B1 (en) | 1980-02-29 | 1986-08-06 | Kefalas As | Indane derivatives |
DE3139970A1 (de) * | 1981-10-08 | 1983-04-28 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
US5026853A (en) * | 1987-04-01 | 1991-06-25 | Janssen Pharmaceutica N.V. | 4-substituted-2(or 3)aminocarbonyl-1-piperazineacetamide |
US5466806A (en) * | 1989-02-08 | 1995-11-14 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
US5643784A (en) * | 1990-12-04 | 1997-07-01 | H, Lundbeck A/S | Indan derivatives |
CZ287406B6 (cs) | 1991-11-05 | 2000-11-15 | Smithkline Beecham Corporation | Indanové a indenové deriváty, způsob jejich výroby a farmaceutické prostředky s jejich obsahem |
CA2091204C (en) * | 1992-03-11 | 1997-04-08 | Ronald J. Mattson | Antiischemic-piperazinyl and piperidinyl-cyclohexanes |
DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
JPH06184132A (ja) | 1992-12-22 | 1994-07-05 | Kotobuki Seiyaku Kk | ベンゾフラン誘導体及びその製造方法並びに尿酸排泄剤 |
CA2176500C (en) | 1993-11-30 | 1999-09-28 | George J. Quallich | Process for preparing a chiral tetralone |
CA2132411A1 (en) * | 1994-09-19 | 1996-03-20 | Michael Trani | Enzymatic esterification of long-chain racemic acids and alcohols |
US6410794B1 (en) | 1994-12-16 | 2002-06-25 | Uop Llc | Process for preparation of pharmaceutically desired chiral tetralone from tetralones |
US6455736B1 (en) * | 1994-12-16 | 2002-09-24 | Uop Llc | Process for preparation of pharmaceutically desired sertraline and sertraline analogs |
US5807897A (en) * | 1996-03-01 | 1998-09-15 | Zeneca Limited | Aminotetralin derivative and compositions and method of use thereof |
US6268367B1 (en) | 1998-02-23 | 2001-07-31 | Zymogenetics, Inc. | Piperazine derivatives for treating bone deficit conditions |
ES2211080T3 (es) | 1998-05-01 | 2004-07-01 | Pfizer Products Inc. | Procedimiento para la produccion de sertralina tetralona enantiomericamente pura u opticamente enriquecida usando cromatografia continua. |
CN1229351C (zh) | 1998-05-22 | 2005-11-30 | 西奥斯股份有限公司 | 杂环化合物和治疗心力衰竭及其它疾病的方法 |
DE19824470A1 (de) * | 1998-05-30 | 1999-12-02 | Boehringer Ingelheim Pharma | Neue Neurokininantagonisten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
GB9818916D0 (en) | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Use |
FR2786769B1 (fr) * | 1998-12-04 | 2002-10-25 | Synthelabo | Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique |
EP1059302A1 (en) | 1999-06-08 | 2000-12-13 | Aventis Pharma Deutschland GmbH | Factor VIIa inhibitors |
JP2000351773A (ja) | 1999-06-08 | 2000-12-19 | Yamanouchi Pharmaceut Co Ltd | フラン誘導体からなる医薬 |
AR031520A1 (es) | 1999-06-11 | 2003-09-24 | Vertex Pharma | Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion |
US6369226B1 (en) | 1999-06-21 | 2002-04-09 | Agouron Pharmaceuticals, Inc. | Substituted benzamide inhibitors of rhinovirus 3C protease |
IN187170B (ru) | 2000-01-04 | 2002-02-23 | Sun Pharmaceutical Ind Ltd | |
JP2001325541A (ja) | 2000-05-12 | 2001-11-22 | Nec Telecom Syst Ltd | 電子商取引決済システム及び電子商取引決済方法 |
AU2004265021B2 (en) * | 2003-08-18 | 2010-05-27 | H. Lundbeck A/S | Succinate and malonate salt of trans-4-(IR,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament |
CN101935305B (zh) * | 2003-08-18 | 2013-04-10 | H.隆德贝克有限公司 | 反式-4-((1r,3s)-6-氯-3-苯基茚满-1-基)-1,2,2-三甲基哌嗪及其盐的制备方法及所用中间体 |
TWI453198B (zh) * | 2005-02-16 | 2014-09-21 | Lundbeck & Co As H | 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s)-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法 |
TWI376373B (en) | 2005-02-16 | 2012-11-11 | Lundbeck & Co As H | Crystalline base of a pharmaceutical compound |
MX2007009816A (es) | 2005-02-16 | 2007-09-07 | Lundbeck & Co As H | Sales de tartrato y de malato de trans-1-((1r,3s)-6-cloro-3- fenilindan-1-i1)-3,3-dimetilpiperazina. |
-
2006
- 2006-02-07 TW TW095103996A patent/TWI453198B/zh not_active IP Right Cessation
- 2006-02-14 EA EA200701738A patent/EA018059B1/ru not_active IP Right Cessation
- 2006-02-14 CA CA2597615A patent/CA2597615C/en not_active Expired - Fee Related
- 2006-02-14 AU AU2006215955A patent/AU2006215955B2/en not_active Ceased
- 2006-02-14 ZA ZA200705984A patent/ZA200705984B/xx unknown
- 2006-02-14 US US11/816,383 patent/US8569499B2/en not_active Expired - Fee Related
- 2006-02-14 JP JP2007554424A patent/JP5148289B2/ja not_active Expired - Fee Related
- 2006-02-14 WO PCT/DK2006/000086 patent/WO2006086984A1/en active Application Filing
- 2006-02-14 MX MX2007009814A patent/MX2007009814A/es active IP Right Grant
- 2006-02-14 CN CN2006800052071A patent/CN101137632B/zh not_active Expired - Fee Related
- 2006-02-14 UA UAA200710268A patent/UA106191C2/ru unknown
- 2006-02-14 NZ NZ556517A patent/NZ556517A/en not_active IP Right Cessation
- 2006-02-14 KR KR1020077016237A patent/KR101364365B1/ko not_active IP Right Cessation
- 2006-02-14 AR ARP060100517A patent/AR054735A1/es unknown
- 2006-02-14 BR BRPI0607438-3A patent/BRPI0607438A2/pt not_active IP Right Cessation
- 2006-02-14 EP EP06706057A patent/EP1853574A1/en not_active Withdrawn
- 2006-02-15 MY MYPI20060625A patent/MY148242A/en unknown
-
2007
- 2007-07-12 IL IL184553A patent/IL184553A/en not_active IP Right Cessation
- 2007-09-12 NO NO20074642A patent/NO20074642L/no not_active Application Discontinuation
-
2008
- 2008-08-26 HK HK08109478.4A patent/HK1123544A1/xx not_active IP Right Cessation
-
2009
- 2009-11-24 US US12/625,178 patent/US20100069676A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2597615A1 (en) | 2006-08-24 |
AU2006215955A1 (en) | 2006-08-24 |
CA2597615C (en) | 2014-05-27 |
JP2008530038A (ja) | 2008-08-07 |
TW200716582A (en) | 2007-05-01 |
US8569499B2 (en) | 2013-10-29 |
ZA200705984B (en) | 2009-01-28 |
US20100069676A1 (en) | 2010-03-18 |
EP1853574A1 (en) | 2007-11-14 |
MY148242A (en) | 2013-03-29 |
NZ556517A (en) | 2010-05-28 |
CN101137632B (zh) | 2013-06-19 |
JP5148289B2 (ja) | 2013-02-20 |
AU2006215955B2 (en) | 2011-09-08 |
BRPI0607438A2 (pt) | 2010-04-06 |
IL184553A0 (en) | 2007-10-31 |
KR20070103386A (ko) | 2007-10-23 |
TWI453198B (zh) | 2014-09-21 |
IL184553A (en) | 2014-05-28 |
MX2007009814A (es) | 2007-09-07 |
NO20074642L (no) | 2007-09-12 |
AR054735A1 (es) | 2007-07-11 |
WO2006086984A1 (en) | 2006-08-24 |
EA018059B1 (ru) | 2013-05-30 |
UA106191C2 (ru) | 2014-08-11 |
US20080153847A1 (en) | 2008-06-26 |
KR101364365B1 (ko) | 2014-02-21 |
EA200701738A1 (ru) | 2007-12-28 |
CN101137632A (zh) | 2008-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL184553A0 (en) | Process for making trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine | |
EP1854863A4 (en) | LUMINOPHORE, PROCESS FOR PRODUCING THE SAME, AND APPLICATION | |
MX280092B (es) | Proceso para producir un compuesto de 5 - hidroxi - 4 - tiometilpirazol. | |
IL184974A0 (en) | Process for making (s)-pregabalin | |
ZA200707243B (en) | Process for producing organic carbonates | |
IL188431A0 (en) | Process for preparing 3-arylmethylthio-and 3-heteroarylmethylthio-4,5-dihydro- | |
GB0510546D0 (en) | New process | |
HK1117525A1 (en) | Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3- dimethylpiperazine -1-((1r3s)-6--3--1-)-33- | |
GB0500604D0 (en) | Novel process | |
GB0519758D0 (en) | Novel process | |
GB0503672D0 (en) | New process | |
EP1813596A4 (en) | PROCESS FOR PREPARING ALPHA, ALPHA-DIFLUORAMINE | |
GB0526474D0 (en) | Novel process | |
MX285136B (es) | Metodo de produccion de polieteramina. | |
AU2006271885A8 (en) | Process for the production of 3-oxo-pregn-4-ene-21,17-carbolactones by the metal-free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes | |
WO2007143065A3 (en) | Process for preparing duloxetine and intermediates thereof | |
HU0501144D0 (en) | New process | |
GB0515909D0 (en) | Process for asymmetric catalytic hydrogenation | |
AU2005901350A0 (en) | Process for DNA assembly | |
PL378528A1 (pl) | Sposób wytwarzania hybrydowych katalizatorów cienkowarstwowych | |
EP1914221A4 (en) | PROCESS FOR PRODUCING BIARYLE COMPOUND | |
AP2007004107A0 (en) | General solvent synthesis, production an dutility | |
AU2005904976A0 (en) | Process | |
HU0500178D0 (en) | New process | |
PL377787A1 (pl) | Sposób modyfikacji katalizatorów heterofazowych, zwłaszcza zeolitów, z zastosowaniem plazmy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180214 |